EUVIMEDEUVIMED entdecken
Crossref

Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autologous Peripheral Blood Stem Cell Transplantation After Rituximab-Containing Induction Chemotherapy With In Vivo Purging in Relapsed or Refractory Follicular Lymphoma

Harumi Kato, Hirofumi Taji, Michinori Ogura, Yoshitoyo Kagami, Yasuhiro Oki, Akane Tsujimura, Nobukazu Fuwa, Takeshi Kodaira, Masao Seto, Kazuhito Yamamoto, Yasuo Morishima

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 443-448

DOI: 10.3816/clm.2009.n.087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Harumi Kato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan Division of Molecular Medicine, Aichi Cancer Center Hospital, …. Hauptthemen laut MEDLINE: Peripheral Blood Stem Cell Transplantation, Whole-Body Irradiation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Blood Stem Cell TransplantationWhole-Body IrradiationAdultAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansLymphoma, FollicularMaleMelphalanMiddle AgedRecurrenceRituximabTransplantation, Autologous

Substanzen

Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedRituximabMelphalan

Autor:innen und Institutionen

  • Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan Division of Molecular Medicine, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Zitieren

APA

Kato, H., Taji, H., Ogura, M., Kagami, Y., Oki, Y., Tsujimura, A., Fuwa, N., Kodaira, T., Seto, M., Yamamoto, K., & Morishima, Y. (2009). Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autologous Peripheral Blood Stem Cell Transplantation After Rituximab-Containing Induction Chemotherapy With In Vivo Purging in Relapsed or Refractory Follicular Lymphoma. Clinical Lymphoma and Myeloma, 9(6), 443-448. https://doi.org/10.3816/clm.2009.n.087

Vancouver

Kato H, Taji H, Ogura M, Kagami Y, Oki Y, Tsujimura A, et al. Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autologous Peripheral Blood Stem Cell Transplantation After Rituximab-Containing Induction Chemotherapy With In Vivo Purging in Relapsed or Refractory Follicular Lymphoma. Clinical Lymphoma and Myeloma. 2009;9(6):443-448. doi:10.3816/clm.2009.n.087

BibTeX
@article{Kato2009,
  author = {Kato, Harumi and Taji, Hirofumi and Ogura, Michinori and Kagami, Yoshitoyo and Oki, Yasuhiro and Tsujimura, Akane and Fuwa, Nobukazu and Kodaira, Takeshi and Seto, Masao and Yamamoto, Kazuhito and Morishima, Yasuo},
  title = {Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autologous Peripheral Blood Stem Cell Transplantation After Rituximab-Containing Induction Chemotherapy With In Vivo Purging in Relapsed or Refractory Follicular Lymphoma},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {443--448},
  doi = {10.3816/clm.2009.n.087}
}
Kostenlos starten →